Title 50 — Public Welfare
62 chapters · 605 sections in this title.
N.D.C.C. § 50-24.6-01 Definitions
1.0K chars
As used in this chapter, unless the context otherwise requires: 1. "Board" means the drug use review board. 2. "Compendium" means the American hospital formulary service drug information, United States pharmacopeia-drug information, the DRUGDEX information system, American medica…
N.D.C.C. § 50-24.6-02 Drug use review board
3.7K chars
1. The board is established within the department for the implementation of a drug use review program. 2. The board consists of seventeen members. The pharmacy administrator of the department and the medical consultant to the department are ex officio nonvoting board members who …
N.D.C.C. § 50-24.6-03 Duties of the board
1.3K chars
The board shall: 1. Cooperate with the department to create and implement a prospective and retrospective drug use review program for outpatient prescription drugs under the medical assistance program. This drug use review program must be based on a compendium and drug use review…
N.D.C.C. § 50-24.6-04 Prior authorization program - Certification program
5.4K chars
1. The department shall develop and implement a prior authorization program that meets the requirements of 42 U.S.C. 1396r-8(d) to determine coverage of drug products when a medical assistance recipient's health care provider prescribes a drug that is identified as requiring prio…
N.D.C.C. § 50-24.6-05 Public notice - Applicability
1.4K chars
1. The department shall provide thirty days' notice of all meetings of the board. The notice requirement is met if the department provides notice of the meeting on the department's website and provides, by written or electronic means, individual notice to each person that has req…
N.D.C.C. § 50-24.6-06 Grievances
0.0K chars
Expired under S.L. 2003, ch. 430, § 12.
N.D.C.C. § 50-24.6-07 Appeals
0.1K chars
A medical assistance recipient who is aggrieved by the placement of a drug on prior authorization may appeal as authorized under chapter 28-32.
N.D.C.C. § 50-24.6-08 Financial incentives prohibited
0.4K chars
The department may not offer or pay, directly or indirectly, any material inducement, bonus, or other financial incentive to a participating provider based on the denial or delay of medically necessary and appropriate prescription drug therapy or based on a reduction in the propo…
N.D.C.C. § 50-24.6-09 Maximum allowable costs and use of edits
0.9K chars
1. To promote efficiency and savings in the department's service to eligible medical assistance program recipients, the department shall create and implement the broadest possible list of drugs that can be paid at the maximum allowable costs. To further promote efficiency and sav…
N.D.C.C. § 50-24.6-10 Adoption of rules
0.1K chars
The department shall adopt rules to implement this chapter.